MENU
+Compare
ADXN
Stock ticker: NASDAQ
AS OF
Aug 12 closing price
Price
$8.00
Change
+$0.15 (+1.91%)
Capitalization
8.44M

ADXN Addex Therapeutics Ltd Forecast, Technical & Fundamental Analysis

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company... Show more

ADXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ADXN with price predictions
Aug 12, 2025

ADXN in upward trend: price expected to rise as it breaks its lower Bollinger Band on August 11, 2025

ADXN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 49 cases where ADXN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ADXN's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ADXN as a result. In of 132 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ADXN turned negative on July 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

ADXN moved below its 50-day moving average on July 17, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ADXN crossed bearishly below the 50-day moving average on July 22, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADXN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.818) is normal, around the industry mean (18.823). P/E Ratio (0.000) is within average values for comparable stocks, (53.986). ADXN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.906). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (52.083) is also within normal values, averaging (290.538).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ADXN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADXN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ADXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Chemin des Aulx 12
Phone
+41 228841555
Employees
24
Web
https://www.addextherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADN3.121.16
+59.18%
Advent Technologies Holdings Inc.
TZUP10.210.76
+8.04%
Thumzup Media Corporation
FBK48.971.90
+4.04%
FB Financial Corp
GFS32.841.22
+3.86%
GlobalFoundries
CASS42.410.35
+0.83%
Cass Information Systems

ADXN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADXN has been loosely correlated with ANVS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ADXN jumps, then ANVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADXN
1D Price
Change %
ADXN100%
+1.88%
ANVS - ADXN
43%
Loosely correlated
-1.77%
CVM - ADXN
39%
Loosely correlated
+8.53%
SGMO - ADXN
29%
Poorly correlated
+17.51%
PHAT - ADXN
28%
Poorly correlated
+0.97%
MOLN - ADXN
28%
Poorly correlated
N/A
More